Where you can work from
Location not specified
The listing does not say where you can work from. Missing information is not the same as worldwide: check before applying.
The company's headquarters is not the same as where you may work from. Visa sponsorship only matters if you would relocate; see below.
Visa sponsorship, if you would relocate
Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 1 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Apr 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 1 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Apr 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
About Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time treatment for previously treated advanced melanoma, now approved in three global markets and available at more than 95 authorized treatment centers. The Iovance TIL platform spans registrational trials and next-generation programs in additional solid tumors, including gene-edited and IL-12 tethered TIL therapies, next-generation IL-2, and precision immuno-oncology approaches. As the first and only company to take TIL therapy from concept to a broadly accessible commercial treatment, Iovance operates as an end-to-end cell therapy company, anchored by fully owned, centralized U.S.-based manufacturing that is scaled to serve thousands of cancer patients worldwide each year. For more information, please visit www.iovance.com .
Amtagvi® and its accompanying design marks, Proleukin ® , Iovance ® , and IovanceCares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc. or its subsidiaries. All other trademarks and registered trademarks are the property of their respective owners.
Information on Iovance’s broad, industry-leading patent portfolio is available on the Intellectual Property page on www.iovance.com .
Overview
The Manager, US Commercial Analytics is a hands-on analytical role responsible for delivering actionable regional, territory, and account-level insights that drive Amtagvi and Proleukin commercial performance. As the primary analytics partner to the US field organization, you will translate business questions into analyses, build dashboards and analytical models, and recommend actions that improve field deployment, targeting, and engagement across the growing network of Authorized Treatment Centers (ATCs). You will connect commercial demand signals with operational execution, supporting both current marketed products and upcoming indication launches. This opportunity is suited to an experienced analyst from a biotechnology or pharmaceutical company or a consulting role serving these clients who wants to own analytical work from business question through recommendation and follow-up.
Essential Functions and Responsibilities:
Sub-National & Territory Analytics
• Design, build, and maintain territory-level performance dashboards and scorecards for the US field organization, incorporating ATC-level infusion data, referral patterns, and patient flow metrics
• Develop and execute sub-national analyses including geographic demand modeling, ATC penetration analytics, and regional market opportunity assessments
• Perform territory alignment and optimization analyses to support field force deployment decisions as the ATC network scales beyond 110 centers
• Create ATC-level performance profiles integrating specialty pharmacy data, claims data, patient hub data, and CRM activity to identify growth opportunities and underperforming territories
• Deliver ad-hoc analytical support to Regional Business Directors and Account Managers: clarify the business question, select the analytical approach, validate findings, and translate results into actionable territory-level recommendations; follow up with business partners to assess decisions and outcomes
Field Force Effectiveness
• Design and manage field force effectiveness measurement frameworks, including call activity analytics, reach and frequency optimization, and engagement scoring for ATC-based selling
• Develop targeting and segmentation models for the ATC network, incorporating physician-level prescribing potential, patient referral patterns, and competitive dynamics
• Supp
Apply on employer site ↗